title: Implementing transgenic and embryonic stem cell technology to study gene expression, cell-cell interactions and gene function.
abstract: This review highlights the use of transgenic mice and gene targeting in the study of reproduction, pituitary gene expression, and cell lineage. Since 1980 numerous applications of transgenic animal technology have been reported. Altered phenotypes resulting from transgene expression demonstrated that introduced genes can exert profound effects on animal physiology. Transgenic mice have been important for the study of hormonal and developmental control of gene expression because gene expression in whole animals often requires more DNA sequence information than is necessary for expression in cell cultures. This point is illustrated by studies of pituitary glycoprotein hormone alpha- and beta-subunit gene expression (Kendall et al., Mol Endocrinol 1994; in press [1]. Transgenic mice have also been invaluable for producing animal models of cancer and other diseases and testing the efficacy of gene therapy. In addition, cell-cell interactions and cell lineage relationships have been explored by cell-specific expression of toxin genes in transgenic mice. Recent studies suggest that attenuated and inducible toxins hold promise for future transgene ablation experiments. Since 1987, embryonic stem (ES) cell technology has been used to create numerous mouse strains with targeted gene alterations, contributing enormously to our understanding of the functional importance of individual genes. For example, the unexpected development of gonadal tumors in mice with a targeted disruption of the inhibin gene revealed a potential role for inhibin as a tumor suppressor (Matzuk et al., Nature 1992:360: 313-319 [2]. The transgenic and ES cell technologies will undoubtedly continue to expand our understanding and challenge our paradigms in reproductive biology.
authors.affiliation: Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48109-0618, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Camper
authors.forename: T L
authors.initials: TL
authors.lastname: Saunders
authors.forename: S K
authors.initials: SK
authors.lastname: Kendall
authors.forename: R A
authors.initials: RA
authors.lastname: Keri
authors.forename: A F
authors.initials: AF
authors.lastname: Seasholtz
authors.forename: D F
authors.initials: DF
authors.lastname: Gordon
authors.forename: T S
authors.initials: TS
authors.lastname: Birkmeier
authors.forename: C E
authors.initials: CE
authors.lastname: Keegan
authors.forename: I J
authors.initials: IJ
authors.lastname: Karolyi
authors.forename: M L
authors.initials: ML
authors.lastname: Roller
mesh_terms: D000818:Animals; D002450:Cell Communication; D004622:Embryo, Mammalian; D015870:Gene Expression; D005786:Gene Expression Regulation; D018390:Gene Targeting; D006965:Hyperplasia; D051379:Mice; D008822:Mice, Transgenic; D009857:Oncogenes; D012098:Reproduction / Q000502:physiology; D013234:Stem Cells